<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Establishment of an Effective Radioiodide Thyroid Ablation Protocol in Mice</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-05-23">May 23, 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Kathrin</forename><forename type="middle">A</forename><surname>Schmohl</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Internal Medicine II</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andrea</forename><forename type="middle">M</forename><surname>Müller</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Internal Medicine II</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nathalie</forename><surname>Schwenk</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Internal Medicine II</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kerstin</forename><surname>Knoop</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Internal Medicine II</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Eddy</forename><surname>Rijntjes</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Institut für Experimentelle Endokrinologie</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Josef</forename><surname>Köhrle</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Institut für Experimentelle Endokrinologie</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Heike</forename><surname>Heuer</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution">Leibniz Institute for Environmental Medicine</orgName>
								<address>
									<settlement>Düsseldorf</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><surname>Bartenstein</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Nuclear Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Burkhard</forename><surname>Göke</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Internal Medicine II</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><forename type="middle">J</forename><surname>Nelson</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Medical Policlinic IV</orgName>
								<orgName type="institution">University Hospital of Munich</orgName>
								<address>
									<settlement>Munich</settlement>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><roleName>MD</roleName><forename type="first">Christine</forename><surname>Spitzweg</surname></persName>
							<email>christine.spitzweg@med.uni-muenchen.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Internal Medicine II</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="department">Department of Internal Medicine II</orgName>
								<orgName type="institution">University Hospital of Munich Marchioninistrasse 15</orgName>
								<address>
									<postCode>DE-81377</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Establishment of an Effective Radioiodide Thyroid Ablation Protocol in Mice</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-05-23">May 23, 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">466E15E01C01826D6184481EE22F2BAD</idno>
					<idno type="DOI">10.1159/000381019</idno>
					<note type="submission">Received: November 17, 2014 Accepted after revision: February 16, 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:51+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Thyroid ablation</term>
					<term>Hypothyroidism</term>
					<term>Mouse model</term>
					<term>Radioiodide</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>followed by injection of bovine TSH before the application of 150 μCi (5.5 MBq) 131 I decreased serum T 4 concentrations below the detection limit and significantly increased pituitary TSHβ concentrations.</s><s>The systemic effects of induced hypothyroidism were shown by growth arrest and a decrease in liver DIO1 expression below the detection limit.</s><s>99m Tc-pertechnetate scintigraphy revealed absence of thyroidal 99m Tc-pertechnetate uptake in ablated mice.</s><s>In summary, we report a revised protocol for radioiodide ablation of the thyroid gland in the mouse to generate an in vivo model that allows the study of thyroid hormone action using NIS as a reporter gene.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Mouse models of hypothyroidism increase our understanding of the mechanisms that regulate thyroid hormone action both during normal function and disease.</s></p><p><s>Drug-induced hypothyroidism is a commonly used approach for assessment of thyroid hormone action in rodent models.</s><s>An alternative approach makes use of the thyroid-lethal properties of the radionuclide iodide-131 ( 131 I) to induce hypothyroidism.</s><s>This is based on the ability of thyroid follicular cells to transport and concentrate radioactive iodide due to their expression of the sodium iodide symporter (NIS).</s><s>Several nonthyroidal organs physiologically express NIS, such as salivary glands, gastric mucosa and lactating mammary glands, and therefore possess the ability to actively transport iodide.</s><s>They do not, however, organify and store it.</s><s>These characteristics allow for high thyroid-specific cytotoxicity of 131 I with minimal side effects <ref type="bibr" target="#b0">[1]</ref> .</s></p><p><s>The first report of selective destruction of thyroid tissue by 131 I was published by Hamilton <ref type="bibr" target="#b1">[2]</ref> in 1942.</s><s>Since then, numerous protocols for radioiodide ablation of the mouse thyroid gland have been published with broad variation of the thyroid-lethal dose of 131 I administered to mice ranging from 28 to 1,000 μCi (1-37 MBq) in the presence or absence of stimulation of thyroidal iodide uptake by treatment with a low-iodine diet (LID) for 1-4 weeks or exogenous thyroid-stimulating hormone (TSH) application prior to the administration of radioiodide <ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref> .</s></p><p><s>We and others have shown the potential of NIS as a reporter gene for molecular imaging with a broad range of possible applications <ref type="bibr" target="#b12">[13]</ref><ref type="bibr">[14]</ref><ref type="bibr" target="#b17">[15]</ref><ref type="bibr" target="#b18">[16]</ref><ref type="bibr" target="#b19">[17]</ref><ref type="bibr" target="#b20">[18]</ref><ref type="bibr" target="#b21">[19]</ref><ref type="bibr" target="#b22">[20]</ref><ref type="bibr" target="#b23">[21]</ref><ref type="bibr" target="#b24">[22]</ref><ref type="bibr" target="#b25">[23]</ref><ref type="bibr" target="#b26">[24]</ref> .</s><s>In our previous work, the role of NIS as a reporter gene allowed noninvasive multimodal imaging of functional NIS expression by 99m Tc or 123 I scintigraphy as well as SPECT and 124 I PET imaging that correlated well with the results of ex vivo gamma counter measurements as well as NIS mRNA and protein analysis.</s><s>Stem cells have been the focus of research in gene and cellular therapies.</s><s>To date, these studies have lacked detailed information about the exact in vivo biodistribution, survival and biological compartment of these cells in tissues.</s><s>Genetically engineered mesenchymal stem cells that express NIS allow detailed noninvasive in vivo tracking of stem cells from their initial deposition to survival, migration and differentiation by 123 I scintigraphy/SPECT and 124 I PET, as demonstrated in our previous work <ref type="bibr" target="#b19">[17,</ref><ref type="bibr" target="#b20">18]</ref> .</s></p><p><s>Based on these studies, we are now employing this system to study thyroid hormone action on mesenchymal stem cell biology within the tumor microenvironment.</s><s>In an effort to generate a thyroid-ablated mouse model for the NIS-based evaluation of thyroid hormone action avoiding interference with thyroidal NIS that underlies an exclusive regulation by TSH, in the current study we describe an effective protocol for thyroid radioiodide ablation in mice.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Animals</head><p><s>Male CD1 nu/nu mice from Charles River (Sulzfeld, Germany) were maintained under specific pathogen-free conditions with access to a standard nude mouse diet (2.2 mg/kg iodine; ssniff, Soest, Germany) or LID (&lt;15 μg/kg iodine; ssniff) and tap water ad libitum.</s><s>Animals were allowed to acclimatize for 1 week prior to the start of treatments.</s><s>At the beginning of the experiments, mice weighed 25-30 g with an average body weight of 26.6 ± 1.27 g (mean ± SD).</s><s>At the end of the experiments, animals were sacrificed and tissues and blood were taken for analysis.</s><s>The experimental protocol was approved by the regional governmental commission for animals (Regierung von Oberbayern, Munich, Germany).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Thyroid Radioiodide Ablation</head><p><s>Mice were randomly assigned to different treatment groups.</s><s>For thyroid ablation, animals received a single i.p. injection of 200 μCi <ref type="bibr">(7.4</ref> MBq; according to Kasuga et al. <ref type="bibr" target="#b9">[10]</ref> ; n = 6), 500 μCi (18.5 MBq; according to Gorbman <ref type="bibr" target="#b2">[3]</ref> ; n = 6) or 150 μCi (5.5 MBq; according to Abel et al. <ref type="bibr" target="#b10">[11]</ref> and Barca-Mayo et al. <ref type="bibr" target="#b11">[12]</ref> ; n = 12) of carrier-free 131 I in 250 μl of phosphate-buffered saline containing sodium thiosulfate as a reducing agent (GE Healthcare, Braunschweig, Germany) or saline for control animals (n = 6 for each experiment).</s><s>Animals that received 500 μCi of 131 I were additionally put on LID 1 week prior to radioiodide application.</s><s>Before administration of the 150 μCi of 131 I, mice were fed LID for 1 week and on day 8 received an i.p. injection of 10 mIU of bovine TSH (Sigma, Munich, Germany) 2 h before radioiodide application.</s><s>A subset of radioiodide-ablated animals (n = 6) received daily i.p. injections of 20 ng/g body weight T 4 (Sigma) starting the day after the application of 131 I.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Serum T 4 Measurements</head><p><s>T 4 concentrations were monitored in pooled serum samples from tail vein blood or in individual serum samples after sacrifice.</s><s>Serum total T 4 concentrations were measured in duplicate by radioimmunoassay using a commercially available kit (RIA-4524; DRG Instruments, Marburg, Germany) according to the manufacturer's instructions.</s><s>The samples and calibrators were incubated with radiolabelled tracer in antibody-coated tubes.</s><s>After incubation, the liquid was aspirated and the antibody-bound radiolabelled tracer was counted in a gamma counter (1277 GammaMaster; LKB Wallac, Turku, Finland).</s><s>The limit of quantification was at 10 n M with an intra-assay coefficient of variation of 3.6% at 80 n M and 1.1% at 167 n M .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Whole-Body Planar 99m Tc-Pertechnetate Scintigraphy</head><p><s>Two hours after i.p. injection of 500 μCi (18.5 MBq) of 99m Tcpertechnetate, a gamma emitter that is also transported by NIS <ref type="bibr" target="#b26">[24]</ref> , 99m Tc-pertechnetate accumulation was assessed using a gamma camera equipped with a low-energy high-resolution collimator (e.cam, Siemens, Munich, Germany).</s><s>Imaging studies were performed under inhalational anesthesia using an isoflurane vaporizer.</s><s>Regions of interest were quantified and expressed as a fraction of the injected dose of applied radionuclide in the cervical region.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RNA Extraction and Quantitative Real-Time PCR</head><p><s>After sacrifice, mouse pituitaries and livers were snap frozen on dry ice and stored at -80 ° C until further processing.</s><s>Total RNA was prepared using the RNeasy Mini Kit with QIAshredder (Qiagen, Hilden, Germany) according to the manufacturer's instructions.</s><s>Reverse transcription was performed using SuperScript III First-Strand Synthesis System (Invitrogen Life Technologies, Karlsruhe, Germany).</s><s>Quantitative real-time PCR was run in duplicate with the QuantiTect SYBR Green PCR Kit (Qiagen) in a Mastercycler ep gradient S PCR cycler (Eppendorf, Hamburg, Germany).</s><s>Relative expression levels of pituitary TSHβ and liver deiodinase type 1 (DIO1) were calculated from ΔΔC t values normalized to internal β-actin and 18S rRNA.</s><s>The following primers were used:</s></p><formula xml:id="formula_0">Actb , forward 5 ′ -AAGAGCTATGAGCTGCCTGA-3 ′ , reverse 5 ′ -TACGGATGTCAACGTCACAC-3 ′ ; R18s , forward 5 ′ -CGCAGCTAGGAATAATGGAA-3 ′ , reverse 5 ′ -TCTGATC- GTCTTCGAACCTC-3 ′ ; Tshb , forward 5 ′ -GGGTATTGTAT- GACACGGGATA-3 ′ , reverse 5 ′ -ATTTCCACCGTTCTGTAG- ATGA-3 ′ ; Dio1 , forward 5 ′ -AAGACAGGGCTGAGTTTGGG-3 ′ , reverse 5 ′ -TGAGGAAATCGGCTGTGGAG-3 ′ .</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Analysis</head><p><s>Every data point was generated using 3-6 mice per group.</s><s>Values are reported as means ± SEM or mean fold change ± SEM.</s><s>Statistical significance of T 4 and TSHβ concentrations were tested by two-tailed Student's t tests, and statistical significance of body weight measurements was tested by a two-tailed Mann-Whitney U test ( * p &lt; 0.05; * * p &lt; 0.01; * * * p &lt; 0.001).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="131">I Ablation and T 4 Measurements</head><p><s>Three different protocols for radioiodide ablation of the thyroid gland were compared with the aim of establishing a thyroid-ablated mouse model of hypothyroidism.</s><s>Four weeks after administration of a single dose of 200 μCi of 131 I, serum T 4 concentrations had dropped by 50% in ablated mice compared to untreated control animals ( fig. <ref type="figure" target="#fig_0">1 a)</ref>.</s></p><p><s>By increasing the 131 I dose to 500 μCi with additional treatment with LID for 1 week prior to 131 I application, serum T 4 concentrations dropped below the limit of detection (&lt;10 n M ) as early as 2 weeks after radioiodide administration ( fig. <ref type="figure" target="#fig_0">1 a</ref>).</s><s>However, starting at approximately 1 week after ablation, mice suffered from drastic weight loss and heavy breathing despite T 4 supplementation in a subgroup of mice, and, as a result, had to be sacrificed ( fig. <ref type="figure" target="#fig_0">1 b</ref>).</s></p><p><s>The combination of 1 week of LID and stimulation with TSH prior to administration of 150 μCi of 131 I (LID/ TSH/150 μCi of 131 I) resulted in serum T 4 concentrations below the detection limit within 2 weeks after ablation</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Radioiodide Ablation of Mouse Thyroid</head><p><s>Eur Thyroid J 2015;4(suppl 1):74-80 DOI: 10.1159/000381019 77 that remained stable until the end of the observation period (10 weeks after ablation; fig. <ref type="figure" target="#fig_0">1 c</ref>).</s><s>The ablated mice without T 4 supplementation showed only minor side effects such as absence of weight gain (fig.</s><s><ref type="figure" target="#fig_2">3</ref>) and slower movement in the cage.</s><s>Therefore, all further experiments were conducted following this protocol.</s><s>Serum T 4 concentrations in the subgroup of mice that received T 4 supplementation by daily i.p. injections of 20 ng of T 4 per gram body weight were in the same range as in the untreated euthyroid group of mice ( fig. <ref type="figure" target="#fig_0">1 c</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Monitoring of Body Weight and Analysis of TSHβ and DIO1 mRNA Expression</head><p><s>The drop in serum T 4 concentrations in ablated mice coincided with a 48-and 45-fold increase, respectively, in pituitary TSHβ concentrations 2 and 10 weeks after thyroid ablation, compared to untreated controls ( fig. <ref type="figure" target="#fig_1">2</ref> ).</s></p><p><s>As a drop in serum T 4 and elevation of pituitary TSH do not per se prove a systemic state of hypothyroidism, we additionally monitored body weight gain in ablated mice versus untreated control mice.</s><s>Radioiodide-ablated mice showed an arrest in growth from around 1 week after 131 I injection, while untreated control animals continued to grow throughout the observation period ( fig. <ref type="figure" target="#fig_2">3</ref> ).</s><s>We also investigated expression of DIO1 in the liver as a second marker for systemic hypothyroidism.</s><s>Four weeks after 131 I application, liver DIO1 mRNA concentrations dropped below the detection limit with C t values &gt;40, whereas for control animals a mean C t value of 26.11 ± 0.69 was measured with comparable reference gene concentrations between the two treatment groups.</s></p><p><s>99m Tc-Pertechnetate Whole-Body Imaging To examine the effects of 131 I ablation on thyroidal radioiodide uptake, we monitored 99m Tc-pertechnetate biodistribution by gamma camera imaging.</s><s>Significant 99m Tc-pertechnetate accumulation was observed in tissues that physiologically express NIS, i.e. thyroid, salivary glands and stomach, as well as the urinary bladder due to renal elimination of the radionuclide ( fig. <ref type="figure" target="#fig_3">4</ref> ).</s><s>Four weeks after 131 I injection, 99m Tc-pertechnetate uptake was strongly reduced in the cervical region of ablated mice with a remaining 99m Tc-pertechnetate uptake of approximately 3-5%, which was caused by the salivary glands that in mice are localized in the direct neighborhood of the thyroid gland and physiologically express NIS ( fig. <ref type="figure" target="#fig_3">4 a</ref>) <ref type="bibr" target="#b27">[25]</ref> .</s><s>In comparison, untreated control mice accumulated approximately 35-40% of the injected dose in the cervical region ( fig. <ref type="figure" target="#fig_3">4 b</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>The aim of the current study was to generate a mouse model in which endogenous thyroid hormone production is abolished to create an experimental paradigm with  a defined baseline for the evaluation of response to thyroid hormone that at the same time allows for the use of NIS as a reporter gene.</s><s>While treatment of mice with antithyroid drugs in drinking water is a widely used approach to render mice hypothyroid, mice have to be treated throughout the experiment, a certain degree of variability remains due to differences in water intake and potential side effects of the drugs have to be taken into consideration <ref type="bibr" target="#b28">[26,</ref><ref type="bibr" target="#b29">27]</ref> .</s><s>Furthermore, as this approach typically relies on a combination of thioamides (methimazole or propylthiouracil) that have been shown to affect thyroidal NIS expression <ref type="bibr" target="#b30">[28]</ref> , as well as the NIS-specific inhibitor perchlorate to block thyroid hormone synthesis, the use of NIS as a reporter gene to study thyroid hormone action is limited in this setting.</s></p><p><s>For these reasons, a reliable method of thyroid radioiodide ablation was developed in mice that exploits the ability of NIS to transport 131 I.</s><s>This eliminates interference of reporter gene activity from thyroidal NIS that is exclusively regulated by TSH and therefore affected by the thyroid hormone status of the mouse.</s><s>A literature search revealed a variety of protocols <ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref> .</s><s>As the 'American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models' <ref type="bibr" target="#b31">[29]</ref> had just been published, we initially tested the protocol described there <ref type="bibr" target="#b9">[10]</ref> .</s><s>Here the recommended 131 I dose of 200 μCi was not sufficient to completely abolish endogenous thyroid hormone production.</s><s>This was most likely due to insufficient accumulation of radioiodide in the thyroid, as mice were fed standard chow containing 2.2 mg/kg iodine, which competes with radioiodide for thyroidal uptake.</s><s>We therefore increased the amount of 131 I to 500 μCi, a dose that was reported by Gorbman <ref type="bibr" target="#b2">[3]</ref> to destroy thyroid tissue within 24 days after radioiodide application.</s><s>In addition, we pretreated mice with LID for 1 week prior to 131 I application to decrease thyroidal iodine content and increase thyroidal NIS expression to enhance the uptake of radioiodide into thyroid follicular cells.</s><s>This treatment decreased serum T 4 concentrations below the detection limit.</s><s>However, mice showed severe side effects, i.e. drastic weight loss and breathing difficulties, starting from around 1 week after iodide injection irrespective of T 4 supplementation, and had to be sacrificed prematurely.</s><s>We assume that the relatively high dose of 131 I, while specifically concentrated in the thyroid, caused severe damage to the thyroid-surrounding tissues, in particular the radiation-sensitive trachea.</s><s>Due to the close proximity of these tissues to the thyroid and the thyroid's small size, the β-particles emitted by 131 I that have a path length of up to 2.4 mm in tissue <ref type="bibr" target="#b32">[30]</ref> can cause lesions in the trachea, recurrent laryngeal nerve and parathyroid glands, as was observed by Gorbman <ref type="bibr" target="#b3">[4]</ref> .</s><s>Furthermore, transient NIS-mediated transport of high doses of radioiodide across epithelia in the gastrointestinal tract may impair their function and lead to subsequent damage.</s></p><p><s>To avoid the aforementioned problems, we adapted protocols published by Abel et al. <ref type="bibr" target="#b10">[11]</ref> and Barca-Mayo et al. <ref type="bibr" target="#b11">[12]</ref> , where relatively low doses of 131 I were reported to be sufficient for total ablation of the thyroid gland under stimulation of 131 I uptake.</s><s>We decided on a protocol consisting of 1 week of LID, followed by an injection of bovine TSH on day 8, 2 h before injection of 150 μCi of 131 I.</s><s>We showed the efficacy of this protocol in inducing hypothyroidism in mice at the level of (1) the first indicators of a disruption of thyroid function, i.e. serum T 4 concentrations and pituitary TSHβ content, (2) indicators of systemic hypothyroidism, i.e. growth arrest and decrease in liver DIO1 concentrations, and (3) the thyroid itself by 99m Tc-pertechnetate gamma camera imaging.</s><s>Two weeks after thyroid ablation, serum T 4 concentrations had dropped below the detection limit and, as expected, pituitary TSHβ concentrations reactively increased 48-fold compared to untreated control mice.</s><s>At the end of the observation period, 10 weeks after thyroid ablation, T 4 concentrations remained undetectable and TSHβ concentrations remained high.</s><s>As growth hormone secretion is thyroid hormone sensitive in rodents <ref type="bibr" target="#b33">[31]</ref> , ablated mice showed an arrest in growth as a consequence of decreasing serum thyroid hormone concentrations, indicating systemic hypothyroidism.</s><s>Another marker for systemic thyroid hormone status is liver DIO1, which is downregulated in hypothyroidism <ref type="bibr" target="#b34">[32]</ref> .</s><s>Four weeks after thyroid ablation, liver DIO1 mRNA concentrations had dropped below the detection limit.</s><s>Gamma camera imaging revealed a significant reduction in 99m Tcpertechnetate uptake in the cervical region 4 weeks after thyroid ablation, despite maximal TSH stimulation due to thyroid hormone deficiency in ablated animals.</s><s>The low residual uptake originates from salivary glands that also physiologically express NIS <ref type="bibr" target="#b27">[25,</ref><ref type="bibr" target="#b35">33]</ref> .</s><s>In mice, the submandibular-sublingual salivary gland complex is relatively large in relation to the thyroid and is located in the ventral cervical region in the direct neighborhood of the thyroid, therefore causing an overlapping signal on 123 I or 99m Tc-pertechnetate scintigraphies <ref type="bibr" target="#b36">[34]</ref> .</s><s>As salivary glands do not possess the ability to organify iodine, retention time of the thyroid-ablative dose of 131 I is limited.</s><s>Thus, salivary glands are preserved, at least in part, as is their ability to accumulate 99m Tc-pertechnetate, while thyroidal uptake is completely eliminated, as was shown by whole-body and neck transaxial planar SPECT imaging by Choi et al. <ref type="bibr" target="#b37">[35]</ref> .</s></p><p><s>In conclusion, our data provide an effective protocol for radioiodide ablation of the thyroid gland that renders mice hypothyroid within the course of 2 weeks and abolishes thyroidal radioiodide uptake.</s><s>Based on our findings, we recommend stimulation of NIS-mediated thyroidal iodide uptake by pretreatment with LID and TSH application to help deliver a well-tolerated dose of 150 μCi of 131 I to mice for successful ablation of the thyroid gland.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc><div><p><s>Fig. 1.</s><s>Comparison of radioiodide thyroid ablation protocols.</s><s>a Serum T 4 concentrations 4 weeks after injection of 200 μCi of 131 I and 2 weeks after injection of 500 μCi of 131 I combined with LID compared to untreated controls.</s><s>The lower 131 I dose resulted in a 50% reduction in serum T 4 concentrations only, while the higher dose decreased T 4 below the detection limit (&lt;10 n M ; * * * p &lt; 0.001).</s><s>b Mice injected with 500 μCi of 131 I suffered weight loss irrespective of T 4 supplementation and had to be sacrificed, while untreated control mice showed continuous growth.</s><s>Results are expressed as percent of initial body weight.</s><s>c Serum T 4 concentrations 2 and 10 weeks after treatment with LID/TSH/150 μCi 131 I compared to untreated controls and mice that additionally received 20 ng/g body weight of T 4 .</s><s>This treatment led to undetectable serum T 4 concentrations as early as 2 weeks after 131 I application, which remained undetectable after 10 weeks.</s><s>T 4 -supplemented mice showed T 4 concentrations in the range of the concentrations measured in untreated and therefore euthyroid control animals ( * p &lt; 0.05; * * * p &lt; 0.001).</s></p></div></figDesc><graphic coords="3,139.40,74.69,394.15,164.71" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 .</head><label>2</label><figDesc><div><p><s>Fig. 2. Pituitary TSHβ mRNA expression. 2 and 10 weeks after LID/TSH/150 μCi 131 I treatment, pituitary TSHβ mRNA concentrations were increased significantly 48-and 45-fold, respectively, compared to untreated control mice ( * * p &lt; 0.01; * * * p &lt; 0.001).</s><s>conc.</s><s>= Concentration.</s></p></div></figDesc><graphic coords="4,75.80,73.01,95.44,155.35" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 3 .</head><label>3</label><figDesc><div><p><s>Fig. 3. Body weight analysis.</s><s>While control animals continued to grow throughout the observation period, LID/TSH/150 μCi 131 Itreated mice showed growth arrest starting from around 1 week after thyroid ablation (day 0).</s><s>Results are expressed as percent of initial body weight ( * * p &lt; 0.01).</s></p></div></figDesc><graphic coords="4,317.78,83.33,221.61,134.77" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 4 .</head><label>4</label><figDesc><div><p><s>Fig. 4. Whole-body 99m Tc-pertechnetate scintigraphy.</s><s>4 weeks after LID/TSH/150 μCi 131 I treatment, 99m Tc-pertechnetate gamma camera imaging showed strongly reduced 99m Tc-pertechnetate uptake in the neck region of ablated animals (approx.</s><s>3-5 %; a ) compared to untreated control animals ( b ).</s><s>A representative image for both ablated mice and control mice is shown.</s><s>SG = Salivary glands.</s></p></div></figDesc><graphic coords="5,88.22,78.95,162.11,156.73" type="bitmap" /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Eur Thyroid J 2015;4(suppl 1):74-80 DOI: 10.1159/000381019</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>We are grateful to E.K. Wirth, Institut für Experimentelle Endokrinologie, Charité-Universitätsmedizin Berlin (Berlin, Germany), for providing TSHβ primer sequences and J. Carlsen and R. Oos, Department of Nuclear Medicine, University Hospital of Munich (Munich, Germany), for their assistance with animal care.</s><s>This study was supported by grants from the Deutsche Forschungsgemeinschaft within the Priority Programme SPP1629 to C. Spitzweg and P.J. Nelson (SP 581/6-1), H. Heuer (HE 3418/7-1) and J. Köhrle (KO 922/17-1).</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosure Statement</head><p><s>The authors declare that there are no competing interests.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The sodium iodide symporter: its pathophysiological and therapeutic implications</title>
		<author>
			<persName><forename type="first">C</forename><surname>Spitzweg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Endocrinol (Oxf)</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="559" to="574" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The use of radioactive tracers in biology and medicine</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Hamilton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Radiology</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="541" to="572" />
			<date type="published" when="1942">1942</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Effects of radiotoxic dosages of I131 upon thyroid and contiguous tissues in mice</title>
		<author>
			<persName><forename type="first">A</forename><surname>Gorbman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Soc Exp Biol Med</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="212" to="213" />
			<date type="published" when="1947">1947</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Functional and structural changes consequent to high dosages of radioactive iodine</title>
		<author>
			<persName><forename type="first">A</forename><surname>Gorbman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1177" to="1191" />
			<date type="published" when="1950">1950</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">The effect of complete ablation of thyroid tissue by radioactive iodine on the survival of tumor-bearing mice</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Sloviter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="447" to="449" />
			<date type="published" when="1951">1951</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Skeletal effects of radio-iodine induced thyroid deficiency in mice as influenced by sex, age and strain</title>
		<author>
			<persName><forename type="first">R</forename><surname>Silberberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Silberberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Anat</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="263" to="289" />
			<date type="published" when="1954">1954</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Enhancing effect of thyroxine on tumor growth and metastases in syngeneic mouse tumor systems</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Chiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Deodhar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="3515" to="3518" />
			<date type="published" when="1979">1979</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Divergent changes in murine pituitary concentration of free alpha-and thyrotropin beta-subunits in hypothyroidism and after thyroxine administration</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Ross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Downing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Chin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Kieffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Ridgway</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="187" to="193" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Regulation by thyroxine of the mRNA encoding the alpha subunit of mouse thyrotropin</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Shupnik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Chin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Ross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Downing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Habener</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Ridgway</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">258</biblScope>
			<biblScope unit="page" from="15120" to="15124" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">The effect of xenotransplantation of human thyroid tissue following radioactive iodine-induced thyroid ablation on thyroid function in the nude mouse</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Kasuga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Matsubayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sakatsume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Akasu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Jamieson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Volpé</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Invest Med</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="277" to="281" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Divergent roles for thyroid hormone receptor beta isoforms in the endocrine axis and auditory system</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Abel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Boers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pazos-Moura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Moura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kaulbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zakaria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lowell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Radovick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Liberman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wondisford</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="291" to="300" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Role of type 2 deiodinase in response to acute lung injury (ALI) in mice</title>
		<author>
			<persName><forename type="first">O</forename><surname>Barca-Mayo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">H</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dicosmo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dumitrescu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Moreno-Vinasco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Wade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sammani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mirzapoiazova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Garcia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Refetoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Weiss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="E1321" to="E1329" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene</title>
		<author>
			<persName><forename type="first">K</forename><surname>Klutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Russ</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Willhauck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wunderlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Gildehaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Göke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ogris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Spitzweg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="6079" to="6086" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<title/>
		<author>
			<persName><surname>Schmohl</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title/>
		<idno type="DOI">10.1159/000381019</idno>
	</analytic>
	<monogr>
		<title level="j">Eur Thyroid J</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="74" to="80" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<author>
			<persName><forename type="first">K</forename><surname>Klutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schaffert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Willhauck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Grünwald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Haase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wunderlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Gildehaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Senekowitsch-Schmidtke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Göke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ogris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Spitzweg</surname></persName>
		</author>
		<title level="m">Epidermal growth factor receptor-targeted</title>
				<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene</title>
	</analytic>
	<monogr>
		<title level="j">Mol Ther</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="676" to="685" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Sodium iodide symporter (NIS)-mediated radionuclide ((131)I, (188) Re) therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene delivery</title>
		<author>
			<persName><forename type="first">K</forename><surname>Klutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Willhauck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wunderlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Anton</forename><forename type="middle">M</forename><surname>Senekowitsch-Schmidtke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Göke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Spitzweg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Gene Ther</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1403" to="1412" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Image-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene</title>
		<author>
			<persName><forename type="first">K</forename><surname>Klutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Willhauck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dohmen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wunderlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Knoop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Senekowitsch-Schmidtke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Gildehaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ziegler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fürst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Göke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ogris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Spitzweg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Gene Ther</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1563" to="1574" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Image-guided, tumor stroma-targeted 131 I therapy of hepatocellular cancer after systemic mesenchymal stem cellmediated NIS gene delivery</title>
		<author>
			<persName><forename type="first">K</forename><surname>Knoop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kolokythas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Klutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Willhauck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wunderlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Draganovici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Gildehaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Böning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Göke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Spitzweg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Ther</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1704" to="1713" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">K</forename><surname>Knoop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Schwenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dolp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Willhauck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zischek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hacker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Göke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Spitzweg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Gene Ther</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="306" to="316" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Sodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Grünwald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Klutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Willhauck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Schwenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Senekowitsch-Schmidtke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schwaiger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Göke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Holm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Spitzweg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene Ther</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="625" to="633" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Grünwald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vetter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Klutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Willhauck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Schwenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Senekowitsch-Schmidtke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schwaiger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Göke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Holm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ogris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Spitzweg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nucl Med</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="1450" to="1457" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">EGFR-targeted adenovirus dendrimer coating for improved systemic delivery of the theranostic NIS gene</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Grünwald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vetter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Klutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Willhauck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Schwenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Senekowitsch-Schmidtke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schwaiger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Göke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Holm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ogris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Spitzweg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Ther Nucleic Acids</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">e131</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Trujillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Oneal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mcdonough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Qin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene Ther</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1325" to="1332" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapy</title>
		<author>
			<persName><forename type="first">P</forename><surname>Baril</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Martin-Duque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Vassaux</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="761" to="771" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Penheiter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Russell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Carlson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Gene Ther</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="33" to="47" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands</title>
		<author>
			<persName><forename type="first">C</forename><surname>Spitzweg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Joba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Schriever</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Goellner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Heufelder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="4178" to="4184" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Extrathyroidal actions of antithyroid thionamides</title>
		<author>
			<persName><forename type="first">U</forename><surname>Bandyopadhyay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Biswas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Banerjee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Toxicol Lett</title>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope unit="page" from="117" to="127" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Methimazole-induced hypothyroidism causes cellular damage in the spleen, heart, liver, lung and kidney</title>
		<author>
			<persName><forename type="first">E</forename><surname>Cano-Europa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Blas-Valdivia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Franco-Colin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Gallardo-Casas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ortiz-Butrón</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Histochem</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="1" to="5" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells</title>
		<author>
			<persName><forename type="first">C</forename><surname>Spitzweg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Joba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Heufelder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thyroid</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="821" to="830" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Bianco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Forrest</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Galton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gereben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Kopp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">H</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Obregon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Peeters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Refetoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Sharlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Simonides</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Weiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Williams</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thyroid</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="88" to="168" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Genetically targeted radiotherapy for multiple myeloma</title>
		<author>
			<persName><forename type="first">D</forename><surname>Dingli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Diaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Bergert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Connor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Russell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="489" to="496" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Rapid effects of single small doses of L-thyroxine and triiodo-L-thyronine on growth hormone, as studied in the rat by radioimmunoassy</title>
		<author>
			<persName><forename type="first">F</forename><surname>Hervas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Morreale De Escobar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Escobar</forename><surname>Del Rey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="91" to="101" />
			<date type="published" when="1975">1975</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Type 1 iodothyronine deiodinase is a sensitive marker of peripheral thyroid status in the mouse</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Zavacki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ying</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Christoffolete</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Aerts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>So</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Harney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Larsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Bianco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page" from="1568" to="1575" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Generation of functional thyroid from embryonic stem cells</title>
		<author>
			<persName><forename type="first">F</forename><surname>Antonica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Kasprzyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Opitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Iacovino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">H</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Dumitrescu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Refetoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Peremans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Manto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kyba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Costagliola</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">491</biblScope>
			<biblScope unit="page" from="66" to="71" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Smallanimal radionuclide luminescence imaging of thyroid and salivary glands with Tc99m-pertechnetate</title>
		<author>
			<persName><forename type="first">F</forename><surname>Boschi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pagliazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Cecchini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gorgoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Salgarello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Spinelli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biomed Opt</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page">76005</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Morphometric and functional changes of salivary gland dysfunction after radioactive iodine ablation in a murine model</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thyroid</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1445" to="1451" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
